Catalyst Wire Dossier Catalyst Wire Dossier

azacytidine

azacitidine
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for azacytidine, covering 2019-12-10 to 2023-08-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS) [Phase 1, Phase 2]

See pricing